Convatec Group (LON:CTEC) Reaches New 12-Month High – Time to Buy?

Convatec Group PLC (LON:CTEC – Get Free Report) hit a new 52-week high during mid-day trading on Monday. The stock traded as high as GBX 259.80 and last traded at GBX 258, with a volume of 8,874,752 shares changing hands. The stock had previously closed at GBX 257.40.

Wall Street Analyst Weigh In

CTEC has been the subject of a number of analyst reports. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 315 price target on shares of Convatec Group in a research report on Monday, August 3rd. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 300 price target on shares of Convatec Group in a research note on Wednesday, August 5th. Berenberg Bank decreased their price objective on shares of Convatec Group from GBX 340 to GBX 335 and set a “buy” rating for the company in a report on Friday, September 11th. Deutsche Bank reissued a “buy” rating and issued a GBX 315 price objective on shares of Convatec Group in a research report on Wednesday, August 5th. Finally, Peel Hunt restated an “add” rating and issued a GBX 270 target price on shares of Convatec Group in a research note on Tuesday, August 4th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 305.44.

Get Our Latest Stock Report on Convatec Group

Convatec Group Price Performance

The firm has a fifty day simple moving average of GBX 230.34 and a 200 day simple moving average of GBX 224.01. The company has a market capitalization of £4.93 billion, a PE ratio of 41.61, a P/E/G ratio of 0.93 and a beta of 0.77. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93.

Insider Buying and Selling at Convatec Group

In other news, insider Jens Viebke acquired 24,400 shares of the firm’s stock in a transaction that occurred on Tuesday, October 13th. The stock was purchased at an average cost of GBX 230 per share, for a total transaction of £56,120. 1.00% of the stock is owned by insiders.

Convatec Group Company Profile

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

Further Reading

Receive News & Ratings for Convatec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Convatec Group and related companies with MarketBeat.com's FREE daily email newsletter.